financetom
Business
financetom
/
Business
/
Why Westwater Resources Shares Are Surging Today
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Why Westwater Resources Shares Are Surging Today
Mar 20, 2024 8:24 AM

Westwater Resources, Inc. ( WWR ) shares are trading higher after the company reported FY23 results.

The company didn’t report any revenue from operations since 2009.

The company reported an EPS loss of $(0.15) in 2023, a decrease from $(0.25) in 2022, mainly owing to a $3.1 million cash settlement from the Republic of Turkey and a $1.2 million write-off of accrued uranium royalties, a $0.3 million increase in interest income on investment account, and $0.5 million less exploration expenses.

Product development expenses for 2023 increased 156% to $2.9 million due to continued product development, optimization, and additional sample production for customer evaluation.

Net cash used in operations declined 13% Y/Y to $(11.4) million in 2023 due to receiving $3.1 million of arbitration settlement cash in the fourth quarter.

As of December 31, 2023, Westwater had a cash balance of $10.9 million and has incurred approximately $119.2 million since beginning construction of Phase I of the Kellyton Graphite Plant.

Terence J. Cryan, Executive Chairman, said, “We are especially excited about our first off-take agreement with a major Tier 1 battery manufacturer, the increase in anticipated Phase I production while staying on budget, and the positive anticipated economic results from our initial assessment of the Coosa Graphite Deposit.”

Frank Bakker, President, and CEO, stated, “Westwater is the only U.S.-based natural graphite company under construction on a processing facility that has a multi-year off-take agreement for CSPG, and that has a graphite deposit in the same state as its future processing plant. The accomplishments of the Westwater team were not only significant for 2023, but I believe positions Westwater well for 2024.“

Price Action: WWR shares are trading higher by 11.3% at $0.54 on the last check Wednesday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Newmont, Orla Mining, and First Nation LP Launch $6.6 Million Fund for Indigenous Skills Development
Newmont, Orla Mining, and First Nation LP Launch $6.6 Million Fund for Indigenous Skills Development
Nov 10, 2025
07:16 AM EST, 11/10/2025 (MT Newswires) -- First Nation LP, NYSE-listed Newmont , and Orla Mining ( ORLA ) announced Monday that they have established a $6.6 million education, training, and skills development fund, to be administered by Opiikapawiin Services, a service organization 100% owned by 24 First Nations. The companies said the investment of $6.6 million will be contributed...
Ex-Glencore employees plead not guilty to UK bribery charges ahead of 2027 trial
Ex-Glencore employees plead not guilty to UK bribery charges ahead of 2027 trial
Nov 10, 2025
LONDON, Nov 10 (Reuters) - Four ex-Glencore ( GLCNF ) oil traders on Monday pleaded not guilty in a London court to bribery charges ahead of their trial in 2027. Paul Hopkirk, Ramon Labiaga, David Perez and Martin Wakefield pleaded not guilty to charges of conspiring to give corrupt payments relating to Glencore's ( GLCNF ) operations in Nigeria, Cameroon...
Cannabis grower Village Farms' Q3 sales beat on higher exports
Cannabis grower Village Farms' Q3 sales beat on higher exports
Nov 10, 2025
Overview * Village Farms ( VFF ) Q3 net sales rise 21% to $66.7 mln, beating analyst expectations * Adjusted EBITDA for Q3 beats estimates, reaching $20.2 mln * Company announces $10 mln share repurchase program, reflecting confidence in financial position Outlook * Company expects Dutch facility expansion to be operational in Q1 2026 * Village Farms anticipates entering new...
Ionis Says Olezarsen Meets Primary Endpoint in Phase 3 Trials in Severe Hypertriglyceridemia
Ionis Says Olezarsen Meets Primary Endpoint in Phase 3 Trials in Severe Hypertriglyceridemia
Nov 10, 2025
07:18 AM EST, 11/10/2025 (MT Newswires) -- Ionis Pharmaceuticals ( IONS ) said over the weekend that two phase 3 studies of olezarsen in people with severe hypertriglyceridemia met the primary endpoint. The drug reduced fasting triglyceride levels by up to 72% at six months, and 86% of treated patients achieved triglyceride levels below the risk threshold for acute pancreatitis,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved